{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:31:02Z","timestamp":1791405062661,"version":"4.3.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hered Cancer Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Determine the proportion of patients with Lynch syndrome who received guideline-concordant care according to NCCN guidelines during the study period (2015\u20132018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was performed at Kaiser Permanente Northern California including patients with germline pathogenic variants in MLH1, MSH2\/EPCAM, MSH6 or PMS2 tested between 01\/01\/2015 and 12\/31\/2018. Clinical and demographic characteristics were abstracted from chart review. Screenings were assessed for gynecologic, gastrointestinal (GI), urinary, skin, and neurologic cancer sites. Concordance was assessed against NCCN guidelines (versions 1.2015 through 1.2018) matched to the year of each patient encounter. The primary outcome was receipt of guideline-concordant care. Secondary outcomes included rates of under- and over-utilization and clinical\/demographic factors associated with care utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 234 patients: 46 with pathogenic MLH1 variants, 64 with MSH6, 83 with PMS2 and 41 with MSH2\/EPCAM variants. Median age was 52 years (IQR: 39\u201362), most were white (60%) and 29% were tested based on a personal cancer history. Half (48%) of patients received screening as recommended by NCCN guidelines, with highest concordance for GI cancer screening. A quarter of patients received less screening than recommended by guidelines. Patients with MLH1 variants had higher rates of transvaginal ultrasound (34.2%) and urologic cancer screening (28.3%) compared to those with other variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Only 48% of patients in this integrated healthcare system received guideline-concordant Lynch syndrome surveillance. Our findings highlight variation in screening practices across pathogenic variant types and suggest opportunities for improving adherence to recommended screenings within healthcare systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13053-026-00334-1","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:06:02Z","timestamp":1773918362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utilization of care and alignment of screening with NCCN guidelines for patients with Lynch syndrome: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Christina","family":"Lowry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameek K.","family":"Bindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bethan","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"334_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2011.01091","author":"A Auranen","year":"2011","unstructured":"Auranen A, Joutsiniemi T. A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families. Acta Obstet Gynecol Scand. 2011. https:\/\/doi.org\/10.1111\/j.1600-0412.2011.01091.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"334_CR2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0693","author":"AK Win","year":"2017","unstructured":"Win AK, et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2017. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0693.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"334_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.743","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011. https:\/\/doi.org\/10.1001\/jama.2011.743.","journal-title":"JAMA"},{"key":"334_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000267500.27329.85","author":"LM Chen","year":"2007","unstructured":"Chen LM, et al. Gynecologic cancer prevention in Lynch syndrome\/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol. 2007. https:\/\/doi.org\/10.1097\/01.AOG.0000267500.27329.85.","journal-title":"Obstet Gynecol"},{"key":"334_CR5","unstructured":"Gupta S, Weiss JM, et al. Genetic\/familial high-risk assessment: colorectal. National Comprehensive Cancer Network (NCCN); 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_colon.pdf"},{"issue":"8","key":"334_CR6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.6004\/jnccn.2016.0108","volume":"14","author":"D Provenzale","year":"2016","unstructured":"Provenzale D, et al. Genetic\/familial high-risk assessment: colorectal version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(8):1010\u201330. https:\/\/doi.org\/10.6004\/jnccn.2016.0108.","journal-title":"J Natl Compr Canc Netw"},{"key":"334_CR7","doi-asserted-by":"publisher","unstructured":"Yurgelun MB, Hampel H. Recent advances in Lynch syndrome: diagnosis, treatment, and cancer prevention. Am Soc Clin Oncol Educ Book. 2018. https:\/\/doi.org\/10.1200\/EDBK_208341.","DOI":"10.1200\/EDBK_208341"},{"issue":"4","key":"334_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41436-020-01029-1","volume":"23","author":"M Dominguez-Valentin","year":"2021","unstructured":"Dominguez-Valentin M, et al. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a prospective Lynch syndrome database report. Genet Med. 2021;23(4):705\u201312. https:\/\/doi.org\/10.1038\/s41436-020-01029-1.","journal-title":"Genet Med"},{"key":"334_CR9","unstructured":"Kaiser Permanente. Fast facts; 2024. https:\/\/about.kaiserpermanente.org\/who-we-are\/fast-facts"},{"key":"334_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1897-4287-9-8","volume":"9","author":"KE Watkins","year":"2011","unstructured":"Watkins KE, et al. Colorectal cancer screening in a large healthcare system: surveillance adherence, outcomes, and missed cases. Hered Cancer Clin Pract. 2011;9:8. https:\/\/doi.org\/10.1186\/1897-4287-9-8.","journal-title":"Hered Cancer Clin Pract"},{"key":"334_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.02.081","author":"M Mork","year":"2015","unstructured":"Mork M, et al. Lynch syndrome: a primer for urologists and panel recommendations. J Urol. 2015. https:\/\/doi.org\/10.1016\/j.juro.2015.02.081.","journal-title":"J Urol"},{"key":"334_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1529","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos F, et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 2009. https:\/\/doi.org\/10.1001\/jama.2009.1529.","journal-title":"JAMA"},{"key":"334_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.3573","author":"D Korenstein","year":"2018","unstructured":"Korenstein D, et al. Development of a conceptual map of negative consequences for patients of overuse of medical tests and treatments. JAMA Intern Med. 2018. https:\/\/doi.org\/10.1001\/jamainternmed.2018.3573.","journal-title":"JAMA Intern Med"},{"key":"334_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13053-023-00263-3","volume":"21","author":"P M\u00f8ller","year":"2023","unstructured":"M\u00f8ller P, et al. Dominantly inherited micro-satellite instable cancer \u2013 the four Lynch syndromes. Hered Cancer Clin Pract. 2023;21:19. https:\/\/doi.org\/10.1186\/s13053-023-00263-3.","journal-title":"Hered Cancer Clin Pract"},{"key":"334_CR15","doi-asserted-by":"publisher","first-page":"101909","DOI":"10.1016\/j.eclinm.2023.101909","volume":"58","author":"M Dominguez-Valentin","year":"2023","unstructured":"Dominguez-Valentin M, et al. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the Prospective Lynch Syndrome Database. eClinicalMedicine. 2023;58:101909. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101909.","journal-title":"eClinicalMedicine"},{"key":"334_CR16","unstructured":"Centers for Disease Control. Tier 1 genomics applications and their importance to public health. https:\/\/archive.cdc.gov\/www_cdc_gov\/genomics\/implementation\/toolkit\/tier1.htm"},{"key":"334_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/gim.0b013e31823375ea","volume":"14","author":"C Bellcross","year":"2012","unstructured":"Bellcross C, et al. Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer. Genet Med. 2012;14:152\u201362. https:\/\/doi.org\/10.1038\/gim.0b013e31823375ea.","journal-title":"Genet Med"}],"container-title":["Hereditary Cancer in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13053-026-00334-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-026-00334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13053-026-00334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:29:34Z","timestamp":1781641774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13053-026-00334-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1186\/s13053-026-00334-1","relation":{},"ISSN":["1897-4287"],"issn-type":[{"value":"1897-4287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}